Pricing

Kiromic BioPharma Inc (KRBP)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Pietro Bersani
Employees:
60
7707 FANNIN ST., SUITE 140, HOUSTON, TX 77054
832-968-4888
Stock Split History
DateRatio
2023-03-13 1:30
Kiromic BioPharma focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available